CD47 and graft versus host disease: Although ILCs lack TCRs and do not cause graft-versus-host disease, allogeneic CAR-ILCs may still trigger host immune rejection, necessitating immune-evasive strategies such as HLA class I knockout or CD47 overexpression (216).